Heidi M Hagen's Insider Trades & SAST Disclosures
Heidi M Hagen's most recent trade in Vericel Corp was a trade of 8,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 30, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Heidi M Hagen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2025 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 3,200 | 31,850 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2025 | 3,200 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 03 Mar 2025 | 9,000 | 37,650 (0%) | 0% | 3.7 | 33,660 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 9,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 03 Mar 2025 | 9,000 | 28,650 (0%) | 0% | 49.5 | 445,770 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 17 Oct 2024 | 6,000 | 28,650 (0%) | 0% | 3.7 | 22,440 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2024 | 6,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Oct 2024 | 4,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.74 per share. | 17 Oct 2024 | 4,000 | 22,650 (0%) | 0% | 3.7 | 14,960 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 8,000 | 8,000 | - | - | Stock Option (Right to Buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 0 | - | - | Restricted Stock Unit | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 3,200 | 18,650 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2023 | 3,200 | 3,200 | - | - | Restricted Stock Unit | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 15,450 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2023 | 2,600 | 0 | - | - | Restricted Stock Unit | |
| Alaunos Therapeutics Inc | Heidi M. Hagen | Director | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 02 Sep 2021 | 23,770 | 145,889 (0%) | 0% | 1.8 | 41,835 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 3,000 | 0 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 19 May 2021 | 3,000 | 8,000 (0%) | 0% | 4.1 | 12,360 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 2,250 | 0 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 19 May 2021 | 2,250 | 10,250 (0%) | 0% | 6 | 13,500 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.00 per share. | 19 May 2021 | 1,500 | 5,000 (0%) | 0% | 6 | 9,000 | Common Stock |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2021 | 1,500 | 0 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 6,500 | 6,500 | - | - | Stock Option (right to buy) | |
| Vericel Corp | Heidi M. Hagen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2021 | 2,600 | 2,600 | - | - | Restricted Stock Unit | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2021 | 1,750 | 3,500 (0%) | 0% | - | Common Stock | |
| Vericel Corp | Heidi M. Hagen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2021 | 1,750 | 0 | - | - | Restricted Stock Unit | |
| Alaunos Therapeutics Inc | Heidi M. Hagen | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 675,000 | 675,000 | - | - | Employee Stock Option (right to buy) | |
| Alaunos Therapeutics Inc | Heidi M. Hagen | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 90,000 | 122,119 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges